MapHabit's First Randomized Control Trial’s Manuscript Fully Approved In A Peer Reviewed Journal

MapHabit's first randomized control trial's manuscript has been fully approved in a peer-reviewed journal.
MapHabit's First Randomized Control Trial’s Manuscript Fully Approved In A Peer Reviewed Journal

MapHabit's first randomized control trial's manuscript has been fully approved in a peer-reviewed journal.

An excerpt from the article:

Plain Language Summary: Efficacy of assistive technology continues to evolve as a means of helping individuals with cognitive and intellectual disabilities. The current study addresses the feasibility of using assistive technology to improve the lives of families living with Alzheimer’s disease and other related dementias. After 6 weeks of using an assistive technology app that helps the user engage in activities of daily living with highly personalized step-by-step visual guides, caregivers reported improved quality of life and completion of activities of daily living for their individual with dementia, all the while reducing burden and stress for themselves. These promising findings underscore the feasibility of using assistive technology in home settings and set the stage for systematic studies of assistive technology’s potential to advance effective behavioral interventions for a wide range of neuro-compromised individuals within home and family settings.

Special thanks to the authors Sam Han, Kaylin White, and Edward Cisek.

View the full PDF of the study here.

Back to Blog